Emmanuelle Charpentier
| Emmanuelle Charpentier | |
|---|---|
| Charpentier in 2015 | |
| Born | Emmanuelle Marie Charpentier 11 December 1968 Juvisy-sur-Orge, France | 
| Education | Pierre and Marie Curie University (BSc, MSc, PhD) | 
| Known for | CRISPR | 
| Awards | 
 | 
| Scientific career | |
| Fields | |
| Institutions | University of Berlin University of Vienna Umeå University Max Planck Society | 
| Thesis | Antibiotic resistance in Listeria spp (1995) | 
| Doctoral advisor | Patrice Courvalin | 
| Website | www | 
Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin. In 2018, she founded an independent research institute, the Max Planck Unit for the Science of Pathogens. In 2020, Charpentier and American biochemist Jennifer Doudna of the University of California, Berkeley, were awarded the Nobel Prize in Chemistry "for the development of a method for genome editing" (through CRISPR). This was the first science Nobel Prize ever won by two women only.